Synnovation Therapeutics
Wilmington, US · Founded 2021 · Delaware corporation · 49 employees on LinkedIn · 3 known investors
A drug discovery company founded by an experienced medicinal chemistry team with expertise in successful pharmaceutical development and clinical advancement.
Founders & leadership
Synnovation Therapeutics was founded in 2021 by Liangxing Wu and Wenqing Yao.
LW
Liangxing WuCo-founder
WY
Wenqing YaoCo-founder
TF
Ting FengNamed on SEC filing
Board
RH
Investors · 3
Reported raises · per SEC filings
Form D private placements$52M disclosed across 3 rounds · 2021–2023
▶$15MraisedDec 2023 · 7 investors · BiotechnologyRule 506(b)
▶$15MraisedDec 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Liangxing WuExecutive Officer, Director
- Wenqing YaoExecutive Officer, Director
- Reid HuberDirector
- Ting FengDirector
- Offering amount
- $102.5M
- Amount sold
- $15M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$25MraisedMay 2023 · 4 investors · BiotechnologyRule 506(b)
▶$25MraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Liangxing WuExecutive Officer, Director
- Reid HuberDirector
- Ting FengDirector
- Wenqing YaoExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$12MraisedNov 2021 · 1 investors · BiotechnologyRule 506(b)
▶$12MraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wenqing YaoExecutive Officer, Director
- Liangxing WuExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $12M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapBioworld10 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Northwest Biotherapeutics9 shared keywordsNorthwest Biotherapeutics is a clinical-stage biotechnology company developing personalized cancer vaccines, marketed under the DCVax platform, that use activated dendritic cells to treat a range of solid tumor cancers. Its product lines include DCVax-L, DCVax-Direct, and DCVax-Prostate.
Companies competing with Synnovation Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Synnovation Therapeutics do?
- A drug discovery company founded by an experienced medicinal chemistry team with expertise in successful pharmaceutical development and clinical advancement.
- Who founded Synnovation Therapeutics?
- Synnovation Therapeutics was founded by Liangxing Wu, Wenqing Yao in 2021.
- Who are Synnovation Therapeutics's investors?
- Synnovation Therapeutics's investors include Nextech Invest, The Innovation Space, Third Rock Ventures.
- How much funding has Synnovation Therapeutics raised?
- Synnovation Therapeutics has disclosed $52M raised across 3 rounds.
- Where is Synnovation Therapeutics headquartered?
- Synnovation Therapeutics is headquartered in Wilmington, US.